Louise Rodino-Klapac

Louise Rodino-Klapac

Chief Tech/Sci/R&D Officer at SAREPTA THERAPEUTICS, INC.

Net worth: 9 M $ as of 30/03/2024

48 year
Health Technology
Consumer Services
Commercial Services

Profile

Founder of Myonexus Therapeutics, Inc., Louise Rodino-Klapac is on the board of Alliance for Regenerative Medicine and Aavantibio, Inc. and Chief Scientific Officer & Executive VP at Sarepta Therapeutics, Inc., Member of American Academy of Neurology and Member of American Society of Gene & Cell Therapy. She previously occupied the position of Chief Scientific Officer at Myonexus Therapeutics, Inc. and Head-Laboratory for Gene Therapy Research at Nationwide Children's Hospital. She received an undergraduate degree from King's College (Pennsylvania) and a doctorate from The Ohio State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
07/03/2024 68,073 ( 0.07% ) 9 M $ 30/03/2024

Louise Rodino-Klapac active positions

CompaniesPositionStart
SAREPTA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 13/12/2020
Director/Board Member 31/12/2020
Corporate Officer/Principal -
Corporate Officer/Principal -
All active positions of Louise Rodino-Klapac

Former positions of Louise Rodino-Klapac

CompaniesPositionEnd
Corporate Officer/Principal 31/05/2019
Founder 31/03/2019
Director/Board Member -
See the detail of Louise Rodino-Klapac's experience

Training of Louise Rodino-Klapac

King's College (Pennsylvania) Undergraduate Degree
The Ohio State University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Louise Rodino-Klapac's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
SAREPTA THERAPEUTICS, INC.

Health Technology

Private companies6

Commercial Services

Health Services

Health Services

Commercial Services

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Louise Rodino-Klapac